Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04399876 |
|
Recruitment Status :
Enrolling by invitation
First Posted : May 22, 2020
Last Update Posted : December 14, 2023
|
Sponsor:
Brigham and Women's Hospital
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Oliver Jonas, Brigham and Women's Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Enrolling by invitation |
|---|---|
| Estimated Primary Completion Date : | March 1, 2025 |
| Estimated Study Completion Date : | March 1, 2026 |